A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clinical trial NCT07164443 · RECRUITING

Trial details

NCT number: NCT07164443
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Neoplasms

Start date: 2025-09-02
Primary completion: 2027-12-29
Enrollment: 1203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.